Changing The Public’s View On Psychedelic Therapeutics With Mydecine Innovation’s Dr. Jetly Oct 1, 2021
Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial Sep 7, 2021
Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School… Aug 18, 2021